Portfolio News

... Liberis (£61 million), Culture Trip (£60 million), and Crescendo Biologics (£53 million). In Europe, a total of £4.2 billion was raised across 631 deals ...

read more

Meet the groundbreaking start-up finding growth at Sci-Tech Daresbury The post Sci-Tech Daresbury post article on Perfectus Biomed’s growth appeared first on Perfectus Biomed.

read more

... are expert speakers James Legg, Vice President R&D, Crescendo Biologics Ltd, and Loui Madakamutil, Vice President, Discovery and Research, ...

read more

Perfectus Biomed will be attending the Center for Biofilm Engineering’s (CBE) upcoming Biofilm Science & Technology meetings next week. The meetings will take place between 17th-19th July, 2018, at the Hilton Garden Inn, Bozeman, Montana.   About the Biofilm Science … Continued The post Perfectus Biomed attending CBE’s 2018 Biofilm Science & Technology meeting in Montana appeared first on Perfectus Biomed.

read more

A 510(k) submission is made to the U.S. Food and Drug Administration (FDA) to demonstrate that a potential new medical device to be marketed is as safe and effective as a product that has already become legally available. However, before … Continued The post The FDA’s 510(k) Submission Process; Common Reasons for Receiving a Refuse-to-Accept (RTA) Decision appeared first on Perfectus Biomed.

read more

1 2 3 5